SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001599298-22-000118
Filing Date
2022-11-09
Accepted
2022-11-09 16:20:41
Documents
74
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q smmt-20220930.htm   iXBRL 10-Q 1134436
2 EX-31.1 sum-ex311_20220930xduggan.htm EX-31.1 11887
3 EX-31.2 sum-ex312_20220930xzanganeh.htm EX-31.2 11966
4 EX-31.3 sum-ex313_20220930xdhingra.htm EX-31.3 11973
5 EX-32.1 sum-ex321_20220930x10q.htm EX-32.1 11148
  Complete submission text file 0001599298-22-000118.txt   5337427

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20220930.xsd EX-101.SCH 41012
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20220930_cal.xml EX-101.CAL 47741
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20220930_def.xml EX-101.DEF 155117
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20220930_lab.xml EX-101.LAB 444187
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20220930_pre.xml EX-101.PRE 319916
68 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20220930_htm.xml XML 808826
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36866 | Film No.: 221372954
SIC: 2834 Pharmaceutical Preparations